- Home
- HOMB vs XENE Comparison
HOMB vs XENE Comparison
Compare HOMB & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOMB | XENE |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.2B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HOMB | XENE |
|---|---|---|
| Price | $30.87 | $63.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $31.50 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 1.5M | 599.0K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | ★ 19.90 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $5.14 | $2,496.48 |
| P/E Ratio | $26.14 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.50 | $35.60 |
| 52 Week High | $31.70 | $72.66 |
Technical Indicators
Market Signals| Indicator | HOMB | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 47.89 |
| Support Level | $30.51 | $61.16 |
| Resistance Level | $31.70 | $66.40 |
| Average True Range (ATR) | 0.46 | 2.06 |
| MACD | -0.12 | -0.40 |
| Stochastic Oscillator | 31.00 | 33.78 |
Price Performance
Historical ComparisonAbout HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.